Yalcin AD - Search Results

1

Celik B, Yalcin AD, Bisgin A, Dimitrakopoulou-Strauss A, Kargi A, Strauss LG. Celik B, et al. Among authors: yalcin ad. Med Sci Monit. 2013 Oct 21;19:875-82. doi: 10.12659/MSM.889605. Med Sci Monit. 2013. PMID: 24145180 Free PMC article.

2

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.

Bisgin A, Kargi A, Yalcin AD, Aydin C, Ekinci D, Savas B, Sanlioglu S. Bisgin A, et al. Among authors: yalcin ad. BMC Cancer. 2012 Feb 7;12:58. doi: 10.1186/1471-2407-12-58. BMC Cancer. 2012. PMID: 22313795 Free PMC article.

3

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Bisgin A, Kargi A, Gorczynski RM. Yalcin AD, et al. Med Sci Monit. 2012 Mar;18(3):PI11-5. doi: 10.12659/msm.882504. Med Sci Monit. 2012. PMID: 22367138 Free PMC article.

4

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer.

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: yalcin ad. Clin Lab. 2012;58(5-6):501-5. Clin Lab. 2012. Corrected and republished in: Clin Lab. 2012;58(9-10):1103-7. PMID: 22783581 Corrected and republished.

5

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.

Yalcin AD, Gumuslu S, Parlak GE, Bısgın A. Yalcin AD, et al. Med Sci Monit. 2012 Oct;18(10):CR617-21. doi: 10.12659/msm.883488. Med Sci Monit. 2012. PMID: 23018355 Free PMC article. Clinical Trial.

6

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: yalcin ad. Clin Lab. 2012;58(9-10):1103-7. Clin Lab. 2012. PMID: 23163132

7

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.

Kargi A, Bisgin A, Yalcin AD, Kargi AB, Sahin E, Gumuslu S. Kargi A, et al. Among authors: yalcin ad. Asian Pac J Cancer Prev. 2013;14(8):4819-22. doi: 10.7314/apjcp.2013.14.8.4819. Asian Pac J Cancer Prev. 2013. PMID: 24083751 Free article.

8

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients.

Bisgin A, Yalcin AD, Gorczynski RM. Bisgin A, et al. Among authors: yalcin ad. Diabetes Res Clin Pract. 2012 Jun;96(3):e84-6. doi: 10.1016/j.diabres.2012.02.028. Epub 2012 Mar 23. Diabetes Res Clin Pract. 2012. PMID: 22446096

9

Serum soluble tumour necrosis factor related apoptosis-inducing ligand level and peripheral eosinophil count in patients with nasal polyposis.

Bisgin A, Eyigor H, Osma U, Yilmaz MD, Yalcin AD. Bisgin A, et al. Among authors: yalcin ad. J Laryngol Otol. 2015 Mar;129(3):250-3. doi: 10.1017/S0022215114003442. Epub 2015 Feb 6. J Laryngol Otol. 2015. PMID: 25655059

10

IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.

Yalcin AD, Bisgin A, Gorczynski RM. Yalcin AD, et al. Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19. Mediators Inflamm. 2012. PMID: 23316107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters